García-Mata, Jesús
Álamo, Cecilio
de Castro, Javier
Contreras, Jorge
Gálvez, Rafael
Jara, Carlos
Llombart, Antonio
Pérez, Concepción
Sánchez, Pedro
Traseira, Susana
Cruz, Juan-Jesús http://orcid.org/0000-0003-1980-2751
Funding for this research was provided by:
Mundipharma Pharmaceuticals, S.L.
Article History
Received: 15 December 2017
Accepted: 23 December 2017
First Online: 2 May 2018
Compliance with ethical standards
:
: Authors received funds from Mundipharma Pharmaceuticals, S.L. for this research. JG-M, JdC, JC, RG, CJ, AL, CP, PS and J-JC declare no competing interests to declare. CA has been a consultant or has received fees for pharmacological training or congressional participation in the last 3 years of Adamed, Exeltis, Grünenthal, Ferrer, GSK, Janssen Cilag, Juste SAQF, Kyowa Kirin Pharmaceutical, Lundbeck, Mundipharma Pharmaceutical, Normon, Otsuka Pharmaceutical, Pfizer, Rovi, Rubió, Servier and Shire. ST has a full-time job at Mundipharma Pharmaceuticals, S.L.
: The manuscript does not contain clinical studies or patient data. According to Spanish regulations, neither approval from an Ethics Committee nor informed consent from patients were required, because all the data come from a survey of oncologists.
: This research has received funds from Mundipharma Pharmaceuticals, S.L.